academic article

• The genetic basis of early T-cell precursor acute lymphoblastic leukaemia..  Nature.  481:157-163. 2012
• Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate..  Multiple sclerosis (Houndmills, Basingstoke, England).  16:342-350. 2010
• The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models..  Nature biotechnology.  28:827-838. 2010
• Differential effects of chronic hypoxia and intermittent hypocapnic and eucapnic hypoxia on pulmonary vasoreactivity..  Journal of applied physiology (Bethesda, Md. : 1985).  104:110-118. 2008
• A prospective open-label study of glatiramer acetate: over a decade of continuous use in multiple sclerosis patients..  Multiple sclerosis (Houndmills, Basingstoke, England).  12:309-320. 2006
• Neurologic consequence of delaying glatiramer acetate therapy for multiple sclerosis: 8-year data..  Acta neurologica Scandinavica.  111:42-47. 2005
• Glatiramer acetate (Copaxone): comparison of continuous versus delayed therapy in a six-year organized multiple sclerosis trial..  Multiple sclerosis (Houndmills, Basingstoke, England).  9:585-591. 2003